Triple Negative Breast Cancer: Molecular Classification, Prognostic Markers and Targeted Therapies
Publish place: Razavi International Journal of Medicine، Vol: 3، Issue: 2
Publish Year: 1394
نوع سند: مقاله ژورنالی
زبان: English
View: 284
This Paper With 7 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
این Paper در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_RIJO-3-2_002
تاریخ نمایه سازی: 6 اسفند 1398
Abstract:
Context: Triple negative breast cancer (TNBC) is a heterogeneous group of diseases that is negative for esterogen receptor (ER) progesteron receptor (PR) and human epidermal growth factor receptor 2 (HER2). This type of breast cancer is typically high-grade carcinomas, although low-grade tumors occur. The aim of this review is to focus on molecular classification and features, prognostic markers and targeted therapies of triple negative breast cancer.Evidence Acquisition: We searched using electronic databases Pubmed/Medline, Dare, Scopus, Embase, and Cochrane Database of Systematic Reviews with terms of ‘Triple negative breast cancer’, ‘Breast cancer’, ‘Molecular classification’, ‘Immunohistochemical markers’, ‘Molecular features, ‘Targeted therapy’, and ‘Prognostic marker’.Results: It seems that TNBC itself can be subdivided into immunomodulatory, mesenchymal, mesenchymal stem-like, luminal androgen receptor, and distinct basal-like subtypes that differ substantially from basal-like tumors. There are several prognostic makers for TNBC including EGFR and ALDH1, Lysyl Oxidase-Like 2 protein (LOXL2), Synuclein gamma (SNCG), LDHB (Lactate Dehydrogenase B). The antiangiogenic agents, EGFR inhibitors, and PARP inhibitors are new therapeutic Implications and potent factors to targeted therapies of TNBC.Conclusions: Only a few clinical trials are performed on TNBC patients because this disease has a low incidence. Therefore, it seems larger scale clinical trials are needed to be conducted in the future.
Keywords:
Authors
Narges Jafarzadeh
Department of Research and Education, Razavi Hospital, Mashhad, IR Iran
Hami Ashraf
Department of Research and Education, Razavi Hospital, Mashhad, IR Iran- Zakaria Idea and Innovation Support and Leading Center, Tehran, IR Iran
Fahimeh Khoshroo
Department of Research and Education, Razavi Hospital, Mashhad, IR Iran
Alireza Sepehri Shamloo
Student Research Committee, Mashhad University of Medical Sciences, Mashhad, IR Iran
Farzad Bidouei
Department of Research and Education, Razavi Hospital, Mashhad, IR Iran
Kamran Ghaffarzadehgan
Department of Research and Education, Razavi Hospital, Mashhad, IR Iran